Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer

SET nuclear proto-oncogene (SET) deregulation is a novel molecular target in metastatic colorectal cancer (CRC). However, its role in CRC progression and its potential clinical impact in early-stage CRC patients remain unknown. Here, we studied the biological effects of SET on migration using wound-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristóbal, Ion, Torrejón, Blanca, Rubio, Jaime, Santos, Andrea, Pedregal, Manuel, Caramés, Cristina, Zazo, Sandra, Luque, Melani, Sanz-Alvarez, Marta, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463201/
https://www.ncbi.nlm.nih.gov/pubmed/30871013
http://dx.doi.org/10.3390/jcm8030346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463201/
https://www.ncbi.nlm.nih.gov/pubmed/30871013
http://dx.doi.org/10.3390/jcm8030346

Ejemplares similares